Novo Nordisk launched Wegovy HD (semaglutide 7.2 mg) nationwide last week — the highest-dose Wegovy injection to date. In the STEP UP trial (Wharton et al., Lancet Diabetes Endocrinol, 2025), patients on the 7.2 mg dose lost an average of 20.7% of their body weight over 72 weeks, compared to 17.5% on the existing 2.4…